178 related articles for article (PubMed ID: 30541493)
1. Targeting the last polio sanctuaries with Directly Observed Oral Polio Vaccination (DOPV) in northern Nigeria, (2014-2016).
Korir C; Shuaib F; Adamu U; Bawa S; Musa A; Bashir A; Isiaka A; Ningi A; Warigon C; Richard B; Fiona B; Pascal M; Loveday N; Tegegne SG; Abdul-Aziz M; Suleiman A; Mohammed K; Corkum M; Onoka C; Nsubuga P; Yehualashet YG; Vaz RG; Alemu W
BMC Public Health; 2018 Dec; 18(Suppl 4):1314. PubMed ID: 30541493
[TBL] [Abstract][Full Text] [Related]
2. Progress toward poliomyelitis eradication in Nigeria.
Ado JM; Etsano A; Shuaib F; Damisa E; Mkanda P; Gasasira A; Banda R; Korir C; Johnson T; Dieng B; Corkum M; Enemaku O; Mataruse N; Ohuabunwo C; Baig S; Galway M; Seaman V; Wiesen E; Vertefeuille J; Ogbuanu IU; Armstrong G; Mahoney FJ
J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S40-9. PubMed ID: 25316862
[TBL] [Abstract][Full Text] [Related]
3. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.
Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK
J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155
[TBL] [Abstract][Full Text] [Related]
4. Stopping circulatory vaccine-derived poliovirus in Kaduna state by scaling up special interventions in local government areas along rivers of interest- kamacha basin experience, 2013-2015.
Musa AI; Shuaib F; Braka F; Mkanda P; Banda R; Korir C; Tegegne SG; Abdullahi S; Umeh GC; Nomhwange TI; Iyal HA; Ishaku S; Adamu U; Damisa E; Bagana M; Gugong V; Balarabe H; Nsubuga P; Vaz RG
BMC Public Health; 2018 Dec; 18(Suppl 4):1303. PubMed ID: 30541497
[TBL] [Abstract][Full Text] [Related]
5. Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014.
Craig KT; Verma H; Iliyasu Z; Mkanda P; Touray K; Johnson T; Walla A; Banda R; Tegegne SG; Yehualashet YG; Abba B; Ahmad-Shehu A; Takane M; Sutter RW; Nsubuga P; Muhammad AJ; Vaz RG
J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S124-30. PubMed ID: 26908720
[TBL] [Abstract][Full Text] [Related]
6. Experiences from polio supplementary immunization activities in Anambra State, Nigeria.
Onyeka IN; Ilika AL; Ilika FN; Umeh DC; Onyibe RI; Okoye CJ; Diden G; Onubogu CU
Niger J Clin Pract; 2014; 17(6):808-13. PubMed ID: 25385924
[TBL] [Abstract][Full Text] [Related]
7. Conduct of vaccination in hard-to-reach areas to address potential polio reservoir areas, 2014-2015.
Bawa S; Shuaib F; Saidu M; Ningi A; Abdullahi S; Abba B; Idowu A; Alkasim J; Hammanyero K; Warigon C; Tegegne SG; Banda R; Korir C; Yehualashet YG; Bedada T; Martin C; Nsubuga P; Adamu US; Okposen B; Braka F; Wondimagegnehu A; Vaz RG
BMC Public Health; 2018 Dec; 18(Suppl 4):1312. PubMed ID: 30541501
[TBL] [Abstract][Full Text] [Related]
8. Using the polio programme to deliver primary health care in Nigeria: implementation research.
Bawa S; McNab C; Nkwogu L; Braka F; Obinya E; Galway M; Mirelman AJ; Hammanyero KI; Safiyanu G; Chukwuji M; Ongwae K; Mkanda P; Corkum M; Hegg L; Tollefson D; Umar S; Audu S; Gunda H; Chinta M; Jean Baptiste AE; Bagana M; Shuaib F
Bull World Health Organ; 2019 Jan; 97(1):24-32. PubMed ID: 30618462
[TBL] [Abstract][Full Text] [Related]
9. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
[TBL] [Abstract][Full Text] [Related]
10. Demand Creation for Polio Vaccine in Persistently Poor-Performing Communities of Northern Nigeria: 2013-2014.
Warigon C; Mkanda P; Muhammed A; Etsano A; Korir C; Bawa S; Gali E; Nsubuga P; Erbeto TB; Gerlong G; Banda R; Yehualashet YG; Vaz RG
J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S79-85. PubMed ID: 26908717
[TBL] [Abstract][Full Text] [Related]
11. Demand-side determinants of timely vaccination of oral polio vaccine in social mobilization network areas of CORE Group polio project in Uttar Pradesh, India.
Choudhary M; Solomon R; Awale J; Dey R
BMC Infect Dis; 2018 May; 18(1):222. PubMed ID: 29769034
[TBL] [Abstract][Full Text] [Related]
12. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
Khan MM; Sharma S; Tripathi B; Alvarez FP
Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
[TBL] [Abstract][Full Text] [Related]
13. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.
Domingues CM; de Fátima Pereira S; Cunha Marreiros AC; Menezes N; Flannery B
J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S143-51. PubMed ID: 25316829
[TBL] [Abstract][Full Text] [Related]
14. Progress toward poliomyelitis eradication--Nigeria, January 2013-September 2014.
Etsano A; Gunnala R; Shuaib F; Damisa E; Mkanda P; Banda R; Korir C; Enemaku O; Corkum M; Usman S; Davis LB; Nganda Gw; Burns CC; Mahoney F; Vertefeuille JF;
MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(46):1059-63. PubMed ID: 25412063
[TBL] [Abstract][Full Text] [Related]
15. Progress toward poliomyelitis eradication--Nigeria, January 2007-August 12, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Aug; 57(34):942-6. PubMed ID: 18756194
[TBL] [Abstract][Full Text] [Related]
16. Lessons learnt from implementing community engagement interventions in mobile hard-to-reach (HTR) projects in Nigeria, 2014-2015.
Hammanyero KI; Bawa S; Braka F; Bassey BE; Fatiregun A; Warigon C; Yehualashet YG; Tegene SG; Banda R; Korir C; Erbeto TB; Chukwuji M; Mkanda P; Adamu US; Nsubuga P
BMC Public Health; 2018 Dec; 18(Suppl 4):1306. PubMed ID: 30541514
[TBL] [Abstract][Full Text] [Related]
17. How vaccine safety can become political--the example of polio in Nigeria.
Clements CJ; Greenough P; Shull D
Curr Drug Saf; 2006 Jan; 1(1):117-9. PubMed ID: 18690921
[TBL] [Abstract][Full Text] [Related]
18. Micro-planning for immunization in Kaduna State, Nigeria: Lessons learnt, 2017.
Umeh GC; Madubu DM; Korir C; Loveday N; Ishaku S; Iyal H; Omoleke SA; I Nomhwange T; Aliyu A; Musa A; Dankoli R; Mi Ningi A; Braka F; Dogo PM; Soba H; Iliyasu N
Vaccine; 2018 Nov; 36(48):7361-7368. PubMed ID: 30366806
[TBL] [Abstract][Full Text] [Related]
19. Transboundary nomadic population movement: a potential for import-export of poliovirus.
Bawa S; Afolabi M; Abdelrahim K; Abba G; Ningi A; Tafida SY; Tegegne SG; Warigon C; Nomhwange T; Umar SA; Aregay A; Fanti A; Ahmed B; Nsubuga P; Adamu U; Braka F; Wondimagegnehu A; Shuaib F
BMC Public Health; 2018 Dec; 18(Suppl 4):1316. PubMed ID: 30541502
[TBL] [Abstract][Full Text] [Related]
20. Progress Toward Poliomyelitis Eradication--Pakistan, January 2014-September 2015.
Farag NH; Wadood MZ; Safdar RM; Ahmed N; Hamdi S; Tangermann RH; Ehrhardt D
MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(45):1271-5. PubMed ID: 26584026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
